Low-dose Combinations with 3 or 4 Blood Pressure-LoweringMedications for the Treatment of Hypertension
by Prateek Chopra | June 5, 2026 | Cardiology Conferences | ESH 2026 Study Objective: Evaluate early low-dose triple and quadruple antihypertensive therapy versus stepwise monotherapy across diverse ethnic populations, synthesizing evidence from six landmark RCTs: QUARTET (n=591), TRIUMPH (n=700), QUADRO (n=183), Trident Trial (~1,670), VERONICA (n=300), and CREOLE (n=728). Outcomes included BP reduction, hypertension control, tolerability, and fourth-agent selection in […]